Evidence map›Paper›PMID 40207377›Full record

ArticleCirculation research2025

High-Throughput Echocardiography-Guided Induction of Myocardial Ischemia/Reperfusion in Mice.

Florian Sicklinger, Niklas Hartmann, Attila Kovacs, Carla Weinheimer, Jess Nigro, Tobias Thiemann, Junedh M Amrute, David Schumacher, Moritz P Kornadt, Laura M Wienecke and 13 more

Abstract read
In one paragraph

Article in Circulation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Cu(OH)Particle and fibre toxicology · 2026
    Article
  2. Article
  3. Preclinical Evaluation ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

23 authors.

Florian SicklingerDepartment of Internal Medicine III, University Hospital Heidelberg, Germany (F.S., N.H., T.T., M.P.K., L.M.W., L.R., J.F., T.C.K., M.V., N.F., F.L.).ORCID 0009-0004-6707-1695
Niklas HartmannDepartment of Internal Medicine III, University Hospital Heidelberg, Germany (F.S., N.H., T.T., M.P.K., L.M.W., L.R., J.F., T.C.K., M.V., N.F., F.L.).
Attila KovacsCardiovascular Division, Department of Medicine, Center for Cardiovascular Research, Washington University School of Medicine, St. Louis (N.H., A.K., C.W., J.N., J.M.A., S.D., K.J.L.).
Carla WeinheimerCardiovascular Division, Department of Medicine, Center for Cardiovascular Research, Washington University School of Medicine, St. Louis (N.H., A.K., C.W., J.N., J.M.A., S.D., K.J.L.).ORCID 0000-0001-7922-7512
Jess NigroCardiovascular Division, Department of Medicine, Center for Cardiovascular Research, Washington University School of Medicine, St. Louis (N.H., A.K., C.W., J.N., J.M.A., S.D., K.J.L.).
Tobias ThiemannDepartment of Internal Medicine III, University Hospital Heidelberg, Germany (F.S., N.H., T.T., M.P.K., L.M.W., L.R., J.F., T.C.K., M.V., N.F., F.L.).ORCID 0009-0003-7284-2127
Junedh M AmruteCardiovascular Division, Department of Medicine, Center for Cardiovascular Research, Washington University School of Medicine, St. Louis (N.H., A.K., C.W., J.N., J.M.A., S.D., K.J.L.).ORCID 0000-0002-6851-0168
David SchumacherDepartment of Medicine II (Nephrology, Rheumatology, Clinical Immunology and Hypertension) (D.S., R.K.), Faculty of Medicine, RWTH Aachen University, Germany.ORCID 0000-0002-2308-6543
Moritz P KornadtDepartment of Internal Medicine III, University Hospital Heidelberg, Germany (F.S., N.H., T.T., M.P.K., L.M.W., L.R., J.F., T.C.K., M.V., N.F., F.L.).
Laura M WieneckeDepartment of Internal Medicine III, University Hospital Heidelberg, Germany (F.S., N.H., T.T., M.P.K., L.M.W., L.R., J.F., T.C.K., M.V., N.F., F.L.).ORCID 0000-0001-7587-8422
Lennart RompelDepartment of Internal Medicine III, University Hospital Heidelberg, Germany (F.S., N.H., T.T., M.P.K., L.M.W., L.R., J.F., T.C.K., M.V., N.F., F.L.).
Johannes FischerDepartment of Internal Medicine III, University Hospital Heidelberg, Germany (F.S., N.H., T.T., M.P.K., L.M.W., L.R., J.F., T.C.K., M.V., N.F., F.L.).ORCID 0009-0000-4327-1079
John BachmanThe Jackson Laboratory, Bar Harbor, ME (J.B., O.B., N.R.).ORCID 0000-0002-2912-9911
Olivia BedardThe Jackson Laboratory, Bar Harbor, ME (J.B., O.B., N.R.).ORCID 0009-0008-7888-1895
Shibali DasCardiovascular Division, Department of Medicine, Center for Cardiovascular Research, Washington University School of Medicine, St. Louis (N.H., A.K., C.W., J.N., J.M.A., S.D., K.J.L.).ORCID 0000-0003-1263-8178
Tim C KuhnDepartment of Internal Medicine III, University Hospital Heidelberg, Germany (F.S., N.H., T.T., M.P.K., L.M.W., L.R., J.F., T.C.K., M.V., N.F., F.L.).
Mirko VölkersDepartment of Internal Medicine III, University Hospital Heidelberg, Germany (F.S., N.H., T.T., M.P.K., L.M.W., L.R., J.F., T.C.K., M.V., N.F., F.L.).ORCID 0000-0003-2344-1856
Ralf P BrandesInstitute for Cardiovascular Physiology, Goethe University Frankfurt, Germany (R.P.B.).ORCID 0000-0002-8035-0048
Rafael KramannDepartment of Medicine II (Nephrology, Rheumatology, Clinical Immunology and Hypertension) (D.S., R.K.), Faculty of Medicine, RWTH Aachen University, Germany.ORCID 0000-0003-4048-6351
Nadia RosenthalThe Jackson Laboratory, Bar Harbor, ME (J.B., O.B., N.R.).
Norbert FreyDepartment of Internal Medicine III, University Hospital Heidelberg, Germany (F.S., N.H., T.T., M.P.K., L.M.W., L.R., J.F., T.C.K., M.V., N.F., F.L.).ORCID 0000-0001-7611-378X
Kory J Lavine *Cardiovascular Division, Department of Medicine, Center for Cardiovascular Research, Washington University School of Medicine, St. Louis (N.H., A.K., C.W., J.N., J.M.A., S.D., K.J.L.).ORCID 0000-0003-1948-9945
Florian Leuschner *Department of Internal Medicine III, University Hospital Heidelberg, Germany (F.S., N.H., T.T., M.P.K., L.M.W., L.R., J.F., T.C.K., M.V., N.F., F.L.).ORCID 0000-0003-1157-474X

Funding

Specification and Function of Tissue Resident and Recruited Macrophages in Cardiac Remodeling and Heart FailureR35HL161185 · NHLBI · WASHINGTON UNIVERSITY · PI Kory J. Lavine · 2022 to 2026
$4.3M
HIGH-RESOLUTON ULTRASOUND SYSTEM FOR PHENOTYPIC EVALUATION OF THE CARDIOVASCULAR SYSTEM IN MICES10OD028597 · OD · WASHINGTON UNIVERSITY · PI KOVACS, ATTILA · 2020 to 2020
$378k
NHLBI NIH HHS R35 HL161185NIH HHS S10 OD028597
6 · The paper itself

Abstract

backgroundMouse models of myocardial ischemia with subsequent heart failure are common approaches to examine heart failure pathology and possible treatment strategies. We sought to establish a high-throughput approach for echocardiography-guided induction of myocardial ischemia/reperfusion (IR) in mice.

methodsAfter visualization of the left coronary artery with high-resolution ultrasound imaging and echocardiographic definition of the level of coronary occlusion, the left anterior descending artery was temporarily occluded with 2 micromanipulator-controlled needles. Functional and molecular changes were assessed and compared with commonly performed surgical techniques.

resultsEchocardiography-guided induction of myocardial IR enabled standardized induction of myocardial IR injury with subsequent left ventricular remodeling. Incorporation of various quality control measures throughout the procedure ensured a high success rate and the absence of relevant postinterventional mortality in experienced hands. Compared with surgical approaches, echocardiography-guided induction of myocardial IR showed a quicker recovery time and induced a less pronounced inflammatory response characterized by decreased local and systemic neutrophil counts. Notably, infarct size and subsequent post-myocardial infarction cardiac dysfunction were comparable between methods. The novel procedure was successfully implemented at different academic institutions with imaging expertise and demonstrated high interinstitutional reproducibility.

conclusionsEchocardiography-guided induction of myocardial IR enables high-throughput induction of myocardial IR injury with precise echocardiographic definition of the occlusion level and immediate evaluation of cardiac function during ischemia. The method provides a more clinically relevant assessment of IR sequelae and offers notable animal welfare advantages by eliminating the need for ventilation and thoracotomy, thereby mitigating potential surgery-related confounders.

Indexed as

EchocardiographyMyocardial Reperfusion InjuryAnimalsDisease Models, AnimalMaleMiceMice, Inbred C57BLMyocardial InfarctionVentricular Remodelingechocardiographyheart failureischemiamicereperfusion

Identifiers

PMID40207377
PMCPMC12063682

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.